WilmerHale Counsels Special Committee of Emisphere Technologies in $1.8B Acquisition by Novo Nordisk

• 11.6.2020

On November 6, Emisphere Technologies, Inc. announced that it has entered into a definitive agreement to be acquired by Novo Nordisk A/S in a deal valued at $1.8 billion. Novo Nordisk will acquire Emisphere for $1.35 billion in cash. At the same time, Novo Nordisk has also entered into an agreement to acquire the related royalty stream obligations owed to affiliates of MHR Fund Management LLC for $450 million.

The Board of Directors of Emisphere approved the merger upon the unanimous recommendation of a Special Committee consisting entirely of independent and disinterested Emisphere directors. The deal is subject to customary closing conditions.

The WilmerHale team representing the Special Committee includes Hal Leibowitz and Joseph Conahan.

Read the full press release.